Application of the Milan System for Reporting Salivary Gland Cytopathology to cystic salivary gland lesions.


Journal

Cancer cytopathology
ISSN: 1934-6638
Titre abrégé: Cancer Cytopathol
Pays: United States
ID NLM: 101499453

Informations de publication

Date de publication:
03 2021
Historique:
received: 01 07 2020
revised: 30 08 2020
accepted: 03 09 2020
pubmed: 2 10 2020
medline: 31 7 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Cystic salivary gland lesions present diagnostic challenges on fine-needle aspiration (FNA) specimens that are related to sampling limitations and a broad differential diagnosis. This study evaluated the benefit of applying the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) to a series of cystic salivary gland lesions. The pathology archives at the Johns Hopkins Hospital were searched to identify cystic salivary gland FNA specimens over a 19-year period (2000-2018). Patient demographics, cytomorphologic features, and clinical and surgical follow-up were recorded. The MSRSGC was applied to the cases. The risk of malignancy (ROM) and the risk of neoplasia (RON) were calculated for each category. One hundred seventy-eight cases were identified (96 males and 82 females) with a mean age of 53 years (range, 4-90 years). After the MSRSGC was applied, there were 52 nondiagnostic cases (29.2%), 80 nonneoplastic cases (44.9%), 35 cases of atypia of undetermined significance (AUS; 19.7%), 3 benign neoplasms (1.7%), 3 salivary gland neoplasms of uncertain malignant potential (SUMP; 1.7%), 4 cases suspicious for malignancy (SFM; 2.2%), and 1 malignant case (0.6%). One hundred fifty-six of the 178 patients (87.6%) had follow-up data available. The RON and ROM values for cases with surgical follow-up were 33.3% (3 of 9) and 22.2% (2 of 9) for the nondiagnostic category, 42.9% (9 of 21) and 19% (4 of 21) for the nonneoplastic category, 76.5% (13 of 17) and 29.4% (5 of 17) for the AUS category, 100.0% (2 of 2) and 50.0% (1 of 2) for the SUMP category, and 100% (2 of 2) and 100% (2 of 2) for the SFM category, respectively. Applying the MSRSGC to cystic salivary gland lesions improves patient management by preventing unnecessary surgery for nonneoplastic conditions. The ROM was highest in the SFM category (100%), which was followed by the SUMP, AUS, nondiagnostic, and nonneoplastic categories. Less than adequate specimens may increase the diagnosis of AUS.

Sections du résumé

BACKGROUND
Cystic salivary gland lesions present diagnostic challenges on fine-needle aspiration (FNA) specimens that are related to sampling limitations and a broad differential diagnosis. This study evaluated the benefit of applying the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) to a series of cystic salivary gland lesions.
METHODS
The pathology archives at the Johns Hopkins Hospital were searched to identify cystic salivary gland FNA specimens over a 19-year period (2000-2018). Patient demographics, cytomorphologic features, and clinical and surgical follow-up were recorded. The MSRSGC was applied to the cases. The risk of malignancy (ROM) and the risk of neoplasia (RON) were calculated for each category.
RESULTS
One hundred seventy-eight cases were identified (96 males and 82 females) with a mean age of 53 years (range, 4-90 years). After the MSRSGC was applied, there were 52 nondiagnostic cases (29.2%), 80 nonneoplastic cases (44.9%), 35 cases of atypia of undetermined significance (AUS; 19.7%), 3 benign neoplasms (1.7%), 3 salivary gland neoplasms of uncertain malignant potential (SUMP; 1.7%), 4 cases suspicious for malignancy (SFM; 2.2%), and 1 malignant case (0.6%). One hundred fifty-six of the 178 patients (87.6%) had follow-up data available. The RON and ROM values for cases with surgical follow-up were 33.3% (3 of 9) and 22.2% (2 of 9) for the nondiagnostic category, 42.9% (9 of 21) and 19% (4 of 21) for the nonneoplastic category, 76.5% (13 of 17) and 29.4% (5 of 17) for the AUS category, 100.0% (2 of 2) and 50.0% (1 of 2) for the SUMP category, and 100% (2 of 2) and 100% (2 of 2) for the SFM category, respectively.
CONCLUSIONS
Applying the MSRSGC to cystic salivary gland lesions improves patient management by preventing unnecessary surgery for nonneoplastic conditions. The ROM was highest in the SFM category (100%), which was followed by the SUMP, AUS, nondiagnostic, and nonneoplastic categories. Less than adequate specimens may increase the diagnosis of AUS.

Identifiants

pubmed: 33002347
doi: 10.1002/cncy.22363
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

214-225

Informations de copyright

© 2020 American Cancer Society.

Références

Eytan DF, Yin LX, Maleki Z, et al. Utility of preoperative fine needle aspiration in parotid lesions. Laryngoscope. 2018;128:398-402.
Layfield LJ, Glasgow BJ. Diagnosis of salivary gland tumors by fine-needle aspiration cytology: a review of clinical utility and pitfalls. Diagn Cytopathol. 1991;7:267-272.
Schmidt RL, Hall BJ, Wilson AR, Layfield LJ. A systematic review and meta-analysis of the diagnostic accuracy of fine-needle aspiration cytology for parotid gland lesions. Am J Clin Pathol. 2011;136:45-59.
Layfield LJ, Gopez E, Hirschowitz S. Cost efficiency analysis for fine-needle aspiration in the workup of parotid and submandibular gland nodules. Diagn Cytopathol. 2006;34:734-738.
Eveson JW, Auclair P, Gnepp DR, El-Naggar AK. Tumours of the salivary glands: introduction. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. IARC Press; 2005.
Faquin WC, Powers CN. Cystic and mucinous lesions: mucocele and low-grade mucoepidermoid carcinoma. In: Faquin WC, Powers CN, eds. Salivary Gland Cytopathology. Springer US; 2008:159-181.
Salehi S, Maleki Z. Diagnostic challenges and problem cases in salivary gland cytology: a 20-year experience. Cancer Cytopathol. 2018;126:101-111.
Layfield LJ, Gopez EV. Cystic lesions of the salivary glands: cytologic features in fine-needle aspiration biopsies. Diagn Cytopathol. 2002;27:197-204.
Faquin WC, Rossi ED, Baloch Z, et al, eds. The Milan System for Reporting Salivary Gland Cytopathology. Springer; 2018.
Allison DB, McCuiston AM, Kawamoto S, Eisele DW, Bishop JA, Maleki Z. Cystic major salivary gland lesions: utilizing fine needle aspiration to optimize the clinical management of a broad and diverse differential diagnosis. Diagn Cytopathol. 2017;45:800-807.
Pantanowitz L, Thompson LDR, Rossi ED. Diagnostic approach to fine needle aspirations of cystic lesions of the salivary gland. Head Neck Pathol. 2018;12:548-561.
Bialek EJ, Jakubowski W. Mistakes in ultrasound examination of salivary glands. J Ultrason. 2016;16:191-203.
Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A. US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls. Radiographics. 2006;26:745-763.
Ahuja AT, Ying M, Yuen HY, Metreweli C. ‘Pseudocystic’ appearance of non-Hodgkin's lymphomatous nodes: an infrequent finding with high-resolution transducers. Clin Radiol. 2001;56:111-115.
Kessler A, Rappaport Y, Blank A, Marmor S, Weiss J, Graif M. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound. 2003;31:21-25.
Carrillo JF, Ramirez R, Flores L, et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses. J Surg Oncol. 2009;100:133-138.
Kim MW, Kim DW, Jung HS, et al. Factors influencing the outcome of ultrasound-guided fine-needle aspiration for salivary gland lesion diagnosis. J Ultrasound Med. 2016;35:877-883.
Takita H, Takeshita T, Shimono T, et al. Cystic lesions of the parotid gland: radiologic-pathologic correlation according to the latest World Health Organization 2017 Classification of Head and Neck Tumours. Jpn J Radiol. 2017;35:629-647.
Ellis GL, Auclair PL, eds. Tumors of the salivary glands. In: AFIP Atlas of Tumor Pathology, 4th Series, Fascicle 9. Silver Spring: ARP Press; 2008.
Upile T, Jerjes W, Al-Khawalde M, et al. Branchial cysts within the parotid salivary gland. Head Neck Oncol. 2012;4:24.
Martinoli C, Pretolesi F, Del Bono V, Derchi LE, Mecca D, Chiaramondia M. Benign lymphoepithelial parotid lesions in HIV-positive patients: spectrum of findings at gray-scale and Doppler sonography. AJR Am J Roentgenol. 1995;165:975-979.
Hughes JH, Volk EE, Wilbur DC; Cytopathology Resource Committee, College of American Pathologists. Pitfalls in salivary gland fine-needle aspiration cytology: lessons from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med. 2005;129:26-31.
Hang JF, Shum CH, Ali SZ, Bishop JA. Cytological features of the Warthin-like variant of salivary mucoepidermoid carcinoma. Diagn Cytopathol. 2017;45:1132-1136.
Wade TV, Livolsi VA, Montone KT, Baloch ZW. A cytohistologic correlation of mucoepidermoid carcinoma: emphasizing the rare oncocytic variant. Patholog Res Int. 2011;2011:135796.
Moatamed NA, Naini BV, Fathizadeh P, Estrella J, Apple SK. A correlation study of diagnostic fine-needle aspiration with histologic diagnosis in cystic neck lesions. Diagn Cytopathol. 2009;37:720-726.

Auteurs

Zahra Maleki (Z)

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland.

Derek B Allison (DB)

Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky.

Monica Butcher (M)

Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland.

Satomi Kawamoto (S)

Department of Radiology, Johns Hopkins Hospital, Baltimore, Maryland.

David W Eisele (DW)

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland.

Liron Pantanowitz (L)

Department of Pathology, University of Michigan, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH